• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球结节病并发慢性肺曲霉病负担。

Global burden of chronic pulmonary aspergillosis complicating sarcoidosis.

机构信息

Manchester Academic Health Science Centre, Manchester, UK.

出版信息

Eur Respir J. 2013 Mar;41(3):621-6. doi: 10.1183/09031936.00226911. Epub 2012 Jun 27.

DOI:10.1183/09031936.00226911
PMID:22743676
Abstract

Chronic pulmonary aspergillosis (CPA) may complicate pulmonary sarcoidosis. We re-estimated the global burden of sarcoidosis and the burden of CPA complicating sarcoidosis. We searched the literature and reference lists of retrieved papers to identify all published sarcoidosis incidence and prevalence data. We estimated the frequency of CPA from 11 papers relating to >3,000 patients with sarcoidosis to derive CPA patient numbers. We applied an annual attrition rate of 15% (range 10-25%) to estimate the global burden of CPA. We estimate that the annual incidence of sarcoidosis is 344,000 patients worldwide and the prevalence is ∼1,238,000 cases, distributed as follows: 165,979 in Europe, 224,000 in the Americas, 492,892 in Africa, 80,023 in the Eastern Mediterranean, 41,660 in the West Pacific and 234,010 in Southeast Asia. CPA complicates sarcoidosis in 3-12% of cases. Using a 6% frequency, we estimate a global burden of 71,907 (range 35,954-143,815 (3-12%)) CPA cases complicating sarcoidosis, with 24% and 37% of cases estimated to be present in the Americas and Africa, because of the higher incidence of sarcoidosis in black people. As CPA responds to long-term antifungal therapy, which may prevent life-threatening haemoptysis, screening periodically for CPA in those with pulmonary sarcoidosis may be important, especially in patients requiring corticosteroid therapy.

摘要

慢性肺曲霉病(CPA)可能使结节病复杂化。我们重新估算了结节病的全球负担以及结节病并发 CPA 的负担。我们检索了文献和检索到的论文参考文献,以确定所有已发表的结节病发病率和患病率数据。我们从 11 篇涉及 3000 多名结节病患者的论文中估算了 CPA 的频率,以得出 CPA 患者人数。我们应用每年 15%(范围为 10%-25%)的衰减率来估算全球 CPA 负担。我们估计,全世界每年结节病的发病率为 344000 例,患病率约为 1238000 例,分布如下:欧洲 165979 例,美洲 224000 例,非洲 492892 例,东地中海 80023 例,西太平洋 41660 例,东南亚 234010 例。CPA 在结节病患者中的发病率为 3%-12%。我们假设发病率为 6%,估算出全世界有 71907 例(范围为 35954-143815 例(3%-12%))结节病并发 CPA,其中 24%和 37%的病例估计出现在美洲和非洲,这是因为黑种人结节病发病率较高。由于 CPA 对长期抗真菌治疗有反应,可能预防威胁生命的咯血,因此定期对有肺部结节病的患者进行 CPA 筛查可能很重要,特别是对需要皮质类固醇治疗的患者。

相似文献

1
Global burden of chronic pulmonary aspergillosis complicating sarcoidosis.全球结节病并发慢性肺曲霉病负担。
Eur Respir J. 2013 Mar;41(3):621-6. doi: 10.1183/09031936.00226911. Epub 2012 Jun 27.
2
Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults.成人哮喘合并变应性支气管肺曲霉病及其并发症慢性肺曲霉病的全球负担。
Med Mycol. 2013 May;51(4):361-70. doi: 10.3109/13693786.2012.738312. Epub 2012 Dec 4.
3
Chronic pulmonary aspergillosis complicating sarcoidosis.并发于结节病的慢性肺曲霉病。
Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.02396-2016. Print 2017 Jun.
4
Estimation of the burden of chronic and allergic pulmonary aspergillosis in India.印度慢性和过敏性肺曲霉病负担的评估。
PLoS One. 2014 Dec 5;9(12):e114745. doi: 10.1371/journal.pone.0114745. eCollection 2014.
5
Chronic pulmonary aspergillosis update: A year in review.慢性肺曲霉病最新进展:年度回顾
Med Mycol. 2019 Apr 1;57(Supplement_2):S104-S109. doi: 10.1093/mmy/myy070.
6
Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation.慢性肺曲霉病常并发于有空洞的治疗后肺结核。
Eur Respir J. 2019 Mar 18;53(3). doi: 10.1183/13993003.01184-2018. Print 2019 Mar.
7
Incidence and prevalence of chronic pulmonary aspergillosis in patients with post-tuberculosis lung abnormality: Results from a community survey in North India.慢性肺曲霉病在肺结核后肺部异常患者中的发病率和患病率:来自印度北部社区调查的结果。
Mycoses. 2024 Mar;67(3):e13711. doi: 10.1111/myc.13711.
8
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.周期性卡泊芬净治疗结节病慢性肺曲霉病。
Thorax. 2014 Mar;69(3):287-8. doi: 10.1136/thoraxjnl-2013-203988. Epub 2013 Sep 12.
9
Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.慢性肺曲霉病作为肺结核的后遗症所带来的全球负担。
Bull World Health Organ. 2011 Dec 1;89(12):864-72. doi: 10.2471/BLT.11.089441. Epub 2011 Sep 27.
10
[Chronic pulmonary aspergillosis].[慢性肺曲霉病]
Nihon Rinsho. 2011 Aug;69(8):1462-7.

引用本文的文献

1
Development of Voriconazole Proliposome Based Dry Powder for Inhalation: A Design of Experiment Approach.伏立康唑前体脂质体吸入用干粉的研制:一种实验设计方法。
Pharmaceutics. 2025 May 8;17(5):622. doi: 10.3390/pharmaceutics17050622.
2
A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).肺结核后患者的隐匿威胁:印度尼西亚多个地区慢性肺曲霉病调查(I-CHROME研究)
J Fungi (Basel). 2025 Apr 22;11(5):329. doi: 10.3390/jof11050329.
3
Fibrotic Pulmonary Sarcoidosis-From Pathogenesis to Management.
纤维化型肺结节病——从发病机制到治疗
J Clin Med. 2025 Mar 30;14(7):2381. doi: 10.3390/jcm14072381.
4
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.慢性肺曲霉病:关于流行病学、治疗及未解决挑战的全面见解
Ther Adv Infect Dis. 2024 Jun 18;11:20499361241253751. doi: 10.1177/20499361241253751. eCollection 2024 Jan-Dec.
5
Imaging of Pulmonary Sarcoidosis-A Review.肺结节病的影像学——综述
J Clin Med. 2024 Jan 31;13(3):822. doi: 10.3390/jcm13030822.
6
Accelerating the understanding of : Epidemiology, physiology, immunology and advances.加速对以下方面的理解:流行病学、生理学、免疫学及进展。
Curr Res Microb Sci. 2024 Jan 11;6:100220. doi: 10.1016/j.crmicr.2024.100220. eCollection 2024.
7
Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis.结节病患者肺纤维化发展中的分子机制。
Int J Mol Sci. 2023 Jun 28;24(13):10767. doi: 10.3390/ijms241310767.
8
Clinical characteristics and predictive model of pulmonary tuberculosis patients with pulmonary fungal coinfection.肺结核合并肺部真菌感染患者的临床特征及预测模型。
BMC Pulm Med. 2023 Feb 7;23(1):56. doi: 10.1186/s12890-023-02344-4.
9
Concomitant occurrence of advanced fibrocavitary pulmonary sarcoidosis and chronic pulmonary aspergillosis.同时发生的晚期纤维空洞性肺结节病和慢性肺曲霉病。
BMJ Case Rep. 2022 Aug 22;15(8):e250751. doi: 10.1136/bcr-2022-250751.
10
Using genomics to understand the mechanisms of virulence and drug resistance in fungal pathogens.利用基因组学理解真菌病原体毒力和耐药性的机制。
Biochem Soc Trans. 2022 Jun 30;50(3):1259-1268. doi: 10.1042/BST20211123.